✦ LIBER ✦
Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma : Sequential Phase II trials by the Cancer and Leukemia Group B
✍ Scribed by Hedy L. Kindler; Chandra P. Belani; James E. Herndon II; Nicholas J. Vogelzang; Yasunosuke Suzuki; Mark R. Green
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 89 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The Cancer and Leukemia Group B (CALGB) conducted sequential Phase II multicenter trials to evaluate the activity of edatrexate alone (E) or with leucovorin rescue (EL) in patients with malignant pleural mesothelioma (CALGB Protocol 9131).